165 related articles for article (PubMed ID: 15088897)
1. Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder.
Park DS; Lee YT; Lee JM
Adv Exp Med Biol; 2003; 539(Pt A):67-85. PubMed ID: 15088897
[TBL] [Abstract][Full Text] [Related]
2. The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma.
Uygur MC; Yaman I; Kutluay L; Altuğ U; Erol D
J Exp Clin Cancer Res; 1999 Sep; 18(3):391-5. PubMed ID: 10606186
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivities of human nonmetastatic clone 23 and p53 products are disassociated and not good predictors of lymph node metastases in early-stage cervical cancer patients.
Tee YT; Wang PH; Ko JL; Chen GD; Chang H; Lin LY
Eur J Gynaecol Oncol; 2007; 28(1):18-22. PubMed ID: 17375700
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
[TBL] [Abstract][Full Text] [Related]
5. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.
Khaled HM; Bahnassy AA; Raafat AA; Zekri AR; Madboul MS; Mokhtar NM
BMC Cancer; 2009 Jan; 9():32. PubMed ID: 19171060
[TBL] [Abstract][Full Text] [Related]
8. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
[TBL] [Abstract][Full Text] [Related]
10. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
Zhou Y; Xu A; Ling X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
13. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.
Shariat SF; Zlotta AR; Ashfaq R; Sagalowsky AI; Lotan Y
Mod Pathol; 2007 Apr; 20(4):445-59. PubMed ID: 17384651
[TBL] [Abstract][Full Text] [Related]
14. Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence?
Feil G; Krause FS; Zumbraegel A; Wechsel HW; Bichler KH
Adv Exp Med Biol; 2003; 539(Pt A):99-109. PubMed ID: 15088899
[No Abstract] [Full Text] [Related]
15. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
16. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
Kim KM; Lee A; Chae HS; Shim SI
J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of p53 Expression Intensity in Urothelial Cancers.
Qamar S; Inam QA; Ashraf S; Khan MS; Khokhar MA; Awan N
J Coll Physicians Surg Pak; 2017 Apr; 27(4):232-236. PubMed ID: 28492153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
